IONIS PHARMACEUTICALS INC — Director's Dealing 2020

Jan 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-01-02

Reporting Person: CROOKE STANLEY T (Director, Executive Chairman of Board)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Employee Stock Option (right to buy)	$60.89	A	141709	Acquired	2027-01-01	Common Stock (141709)	Direct
2020-01-02	Employee Stock Option (right to buy)	$60.89	A	12477	Acquired	2027-01-01	Common Stock (12477)	Indirect

Footnotes

F1: Grant on 01/02/2020 to reporting person or reporting person's wife (as indicated) of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2020. 25% of the shares subject to the option will vest and become exercisable on 01/02/2021. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.